AbbVie Inc. (ABBV) vs Sandisk Corporation (SNDK)

See how AbbVie Inc. and Sandisk Corporation differ across market data and performance, so you can decide which asset best fits your strategy.

$283.54
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page
$755.16
NasdaqGS
Sandisk Corporation is one of the world’s five largest suppliers of NAND flash memory semiconductors. The company is vertically integrated, manufacturing nearly all of its flash chips in Japan through a joint venture with Kioxia. It also repackages most of these chips into SSDs for consumer devices, external storage, and cloud storage applications. Formerly part of Western Digital following its 2016 acquisition, Sandisk operated within the company for nine years before becoming an independent business again in 2025.
View Full Page

Key Metrics Comparison

AbbVie Inc.ABBV
Market Cap
$501.19B
Price
$283.54
24h Change
-0.86%
24h Volume
$5.01M
Employees
57,000
Shares Outstanding
1,768,169,012
Sandisk CorporationSNDK
Market Cap
$859.61B
Price
$755.16
24h Change
-2.71%
24h Volume
$15.1M
Employees
11,000
Shares Outstanding
147,600,972

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ABBV
36.8%
SNDK
63.2%

Volume Share

Share of combined 24h volume

Volume Share
ABBV
24.9%
SNDK
75.1%

24h Performance

Price change over last 24 hours

24h Performance
ABBV
-0.86%
SNDK
-2.71%
Price Comparison
AbbVie Inc.
Sandisk Corporation